RxDoctor Payments Data

Shahira Abdel-Malek, MD

Pediatrics · Huntington Park, CANPI 1295832277

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 12 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Kowa Pharmaceuticals America, Inc. at 44.2% of the total. 2025 is the largest year on record at $216, 2.7 times the $80 reported in 2020.

$361in general payments, 2019–2025

Across 12 payments — averaging $30.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kowa Pharmaceuticals America, Inc.$159
  • Sanofi-aventis U.S. LLC$86
  • GSK$80
  • Merck$19
  • Acadia Pharmaceuticals Inc$15
$185,950in research payments, 2019–2025

Across 27 payments — averaging $6887.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi Pasteur Inc.$186K

What the payments were for

  • Food & beverage$361100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$361 in reported general payments places this provider in the 65th percentile of 5,539 pediatrics providers in California.

See all pediatrics providers in California

Medicare billing

Part B allowed, 2024
$10,562
Medicare patients
20
Services billed
116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclosporine39$11,572
JardianceEmpagliflozin12$6,556
Fluticasone-SalmeterolFluticasone Propion/Salmeterol26$4,130
Fluocinonide15$1,154
Ibandronate Sodium19$673
Diclofenac Sodium30$665
Alcohol Prep PadsAlcohol Antiseptic Pads12$515
Atorvastatin Calcium65$483
Metformin Hcl85$466
Rosuvastatin Calcium45$386
Gabapentin29$317
Valsartan12$314
Ketoconazole16$243
Alendronate Sodium58$233
Glipizide39$226

Paid to pharmacies, not to this prescriber.

Other pediatrics in Huntington Park

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →